Scarica l'app Stockscreener
9.455
1.12%
0.105
Dopo l'orario di chiusura:
9.36
-0.095
-1.00%
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché NVAX Giù?
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$9.35
Aprire:
$9.335
Volume 24 ore:
4.20M
Relative Volume:
0.90
Capitalizzazione di mercato:
$1.55B
Reddito:
$596.34M
Utile/perdita netta:
$-87.84M
Rapporto P/E:
-15.82
EPS:
-0.5975
Flusso di cassa netto:
$-97.62M
1 W Prestazione:
+0.37%
1M Prestazione:
-0.37%
6M Prestazione:
+24.08%
1 anno Prestazione:
+43.04%
Intervallo 1D:
$8.885
$9.48
Intervallo di 1 settimana:
$8.885
$10.12
Portata 52W:
$6.20
$11.97
Novavax Inc Stock (NVAX) Company Profile
Nome
Novavax Inc
Settore
Industria
Telefono
240-268-2000
Indirizzo
21 FIRSTFIELD RD, GAITHERSBURG, MD
Compare NVAX vs VRTX, REGN, ARGX, ALNY, RVMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
NVAX
Novavax Inc
|
9.455 | 1.54B | 596.34M | -87.84M | -97.62M | -0.5975 |
VRTX
Vertex Pharmaceuticals Inc
|
522.25 | 134.41B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
676.23 | 68.13B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
919.93 | 57.01B | 4.16B | 1.29B | 734.26M | 19.58 |
ALNY
Alnylam Pharmaceuticals Inc
|
321.50 | 41.79B | 4.29B | 577.22M | 641.34M | 4.2086 |
RVMD
Revolution Medicines Inc
|
190.46 | 40.39B | 742.00K | -1.37B | -1.07B | -7.0731 |
Novavax Inc Stock (NVAX) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-10-24 | Ripresa | Cantor Fitzgerald | Overweight |
| 2025-08-28 | Ripresa | H.C. Wainwright | Buy |
| 2025-08-20 | Downgrade | BofA Securities | Neutral → Underperform |
| 2025-06-17 | Iniziato | Citigroup | Sell |
| 2025-02-28 | Iniziato | BTIG Research | Buy |
| 2024-07-30 | Downgrade | JP Morgan | Neutral → Underweight |
| 2024-05-10 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2024-05-10 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2023-08-09 | Aggiornamento | B. Riley Securities | Neutral → Buy |
| 2023-04-20 | Downgrade | TD Cowen | Outperform → Market Perform |
| 2023-03-01 | Downgrade | B. Riley Securities | Buy → Neutral |
| 2023-01-09 | Reiterato | B. Riley Securities | Buy |
| 2022-12-30 | Reiterato | H.C. Wainwright | Buy |
| 2022-12-02 | Iniziato | Jefferies | Hold |
| 2022-09-22 | Downgrade | JP Morgan | Neutral → Underweight |
| 2022-05-20 | Iniziato | BofA Securities | Underperform |
| 2022-02-23 | Reiterato | B. Riley Securities | Buy |
| 2022-02-22 | Ripresa | Jefferies | Buy |
| 2022-01-21 | Iniziato | Cowen | Outperform |
| 2021-05-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2020-12-14 | Iniziato | Jefferies | Buy |
| 2020-08-06 | Reiterato | H.C. Wainwright | Buy |
| 2020-08-05 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2020-08-05 | Downgrade | Ladenburg Thalmann | Neutral → Sell |
| 2020-07-16 | Reiterato | H.C. Wainwright | Buy |
| 2020-07-08 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| 2020-06-29 | Reiterato | B. Riley FBR | Buy |
| 2020-06-29 | Reiterato | H.C. Wainwright | Buy |
| 2020-06-05 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-05-28 | Reiterato | B. Riley FBR | Buy |
| 2020-05-12 | Reiterato | H.C. Wainwright | Buy |
| 2020-04-30 | Reiterato | H.C. Wainwright | Buy |
| 2019-11-27 | Ripresa | B. Riley FBR | Buy |
| 2019-08-14 | Reiterato | H.C. Wainwright | Buy |
| 2019-02-28 | Downgrade | Piper Jaffray | Overweight → Underweight |
| 2018-12-18 | Iniziato | Ladenburg Thalmann | Buy |
| 2018-12-11 | Iniziato | Oppenheimer | Outperform |
| 2018-11-26 | Aggiornamento | Piper Jaffray | Neutral → Overweight |
| 2018-09-21 | Aggiornamento | JP Morgan | Underweight → Overweight |
| 2018-03-29 | Aggiornamento | Seaport Global Securities | Neutral → Buy |
Mostra tutto
Novavax Inc Borsa (NVAX) Ultime notizie
AtaiBeckley Completes VLS-01 Dosing in Phase IIb Depression Study - TradingView
Novavax, Inc. (NVAX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo Finance Singapore
Novavax Inc. stock underperforms Monday when compared to competitors - MarketWatch
Does Novavax’s (NVAX) Russell Exit Quietly Recast Its Partnership-Driven, Royalty-Focused Equity Story? - simplywall.st
Novavax (NVAX) Stock Moves 1.36%: What You Should Know - Yahoo Finance
Novavax Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
(NVAX) as a Liquidity Pulse for Institutional Tactics - Stock Traders Daily
NVAX Stock Rises Overnight Ahead Of Q4 Print With Pfizer Tailwinds — Analyst Warns Of 20% Crash - Stocktwits
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
Novavax Stock Hits Over 1-Year High: Is Sanofi’s Flu-COVID Shot The Post-Pandemic Growth Driver? - Stocktwits
Novavax Inc. stock outperforms competitors on strong trading day - MarketWatch
Novavax, Inc.(NasdaqGS:NVAX) dropped from Russell Small Cap Comp Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 2500 Growth Benchmark - marketscreener.com
ETFs Investing in Novavax, Inc. Stocks - TradingView
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 2000 Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000E Growth Benchmark - marketscreener.com
Novavax, Inc.(NasdaqGS: NVAX) dropped from Russell 3000 Growth Benchmark - marketscreener.com
Novavax Q4 Earnings Preview: Wall Street Expects Wider Losses Amid Diversification Efforts - Stocktwits
Price to sales forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Price to sales forward of Novavax, Inc. – FWB:NVV1 - TradingView
Novavax Swings To Profit In Q4 Fueled By Nuvaxovid-Linked Revenue - Stocktwits
Novavax boosts efficiency and productivity with ServiceNow - NTT Data
NVAX News | NOVAVAX INC (NASDAQ:NVAX) - ChartMill
Enterprise value to EBITDA forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Enterprise value to EBITDA forward of Novavax, Inc. – SIX:NVAX - TradingView
Novavax Inc. stock underperforms Friday when compared to competitors despite daily gains - MarketWatch
Enterprise value to revenue forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Investors heavily search Novavax, Inc. (NVAX): Here is what you need to know - MSN
Enterprise value to revenue forward of Novavax, Inc. – SIX:NVAX - TradingView
Price to sales forward of Novavax, Inc. – SIX:NVAX - TradingView
Enterprise value to EBIT forward of Novavax, Inc. – SIX:NVAX - TradingView
Novavax Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Novavax, Inc. Actuals & Estimates (SIX:NVAX) - TradingView
Price to book forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
These Stocks Are Moving the Most Today: Novavax, Palantir, Shoals, Plug Power, DaVita, and More - Barron's
NVAX Forecast — Price Target — Prediction for 2027 - TradingView
Price to earnings forward of Novavax, Inc. – NASDAQ:NVAX - TradingView
Novavax | 4: Statement of changes in beneficial ownership of securities-Director DOUGLAS RICHARD - Moomoo
Novavax (NVAX) Suffers a Larger Drop Than the General Market: Key Insights - Yahoo Finance
Novavax Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Shah Capital campaign falls short at Novavax despite opposition to board, pay - Alternatives Watch
Shah Capital blasts Novavax annual meeting results - The American Bazaar
Novavax faces renewed attack by Shah Capital after AGM - MSN
Novavax Draws Fresh Criticism From Largest Shareholder Shah Capital Following Annual Meeting - citybiz
Novavax (NVAX) Faces Shareholder Backlash Despite AGM Resolutions Approval - GuruFocus
Novavax | 4: Statement of changes in beneficial ownership of securities-Director MOTT DAVID M - Moomoo
Novavax Shareholders Approve Directors, Pay and Incentive Plans - The Globe and Mail
Novavax targeted by Shah Capital after AGM (NVAX:NASDAQ) - Seeking Alpha
Shah Capital Responds to Significant Shareholder Dissent at Novavax AGM - Yahoo Finance
Form 4 Novavax Inc For: 23 June By Investing.com - Investing.com Australia
Novavax (NVAX) director gains RSU and option grants, exercises award - Stock Titan
Novavax Inc Azioni (NVAX) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
1.18%
2.48%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):